Related Experiment Videos
High serum C3 predicts poor outcome in IgM nephropathy
Juhani Myllymäki1, Heikki Saha, Amos Pasternack
1Medical School, University of Tampere, Tampere, Finland.
Nephron. Clinical Practice
|November 12, 2005
Summary
Immunological markers, specifically high serum C3, can predict poor outcomes in IgM nephropathy (IgMN). This finding aids in understanding IgMN prognosis beyond established factors.
Area of Science:
- Nephrology
- Immunology
- Glomerular Diseases
Background:
- IgM nephropathy (IgMN) is characterized by mesangial IgM deposition.
- The underlying causes and associations of immunological factors with IgMN outcomes are not fully understood.
Purpose of the Study:
- To investigate the relationship between serum and mesangial immunoglobulins and complement levels and the renal outcome in IgMN patients.
- To identify immunological parameters that can predict the prognosis of IgMN.
Main Methods:
- Serum levels of IgA, IgG, IgM, C3, and C4 were measured in 110 IgMN patients.
- Mesangial IgA, IgG, IgM, C1q, and C3 were assessed via immunofluorescence.
- Histopathological parameters were semiquantitatively graded, and relationships with immunological findings and clinical outcomes were analyzed.
Main Results:
- Lower serum IgG and higher serum C3 levels were observed in patients with nephrotic syndrome.
- Serum C3 levels correlated with the severity of glomerular histopathological changes.
- A low serum IgG/C3 ratio was the strongest predictor of renal disease progression; serum C3 independently predicted progression in non-nephrotic patients.
Conclusions:
- Immunological parameters, in addition to known factors, can assist in predicting IgMN prognosis.
- Elevated serum C3 is indicative of a poor outcome in IgMN, correlating with proteinuria, severe histopathology, and disease progression.
Related Concept Videos
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...